cui1,cui2,relation,name1,name2,type1,type2,weight,predicate
C0002502,C0234724,NEG_AFFECTS,Amiloride,Secondary visual deviation,orch,clna,1,NEG_AFFECTS_ORCHnafctCLNA
C0019873,C3830527,NEG_AFFECTS,Ethidium Bromide,Detectable,orch,clna,1,NEG_AFFECTS_ORCHnafctCLNA
C0027353,C1456627,NEG_AFFECTS,Nalidixic Acid,Antimicrobial Resistance,orch,clna,1,NEG_AFFECTS_ORCHnafctCLNA
C0034392,C3830527,NEG_AFFECTS,Quercetin,Detectable,orch,clna,1,NEG_AFFECTS_ORCHnafctCLNA
C0034428,C2926606,NEG_AFFECTS,Quinolones,Procedure findings:Finding:Point in time:^Patient:Narrative,orch,clna,1,NEG_AFFECTS_ORCHnafctCLNA
C0068941,C3830527,NEG_AFFECTS,Nonidet P-40,Detectable,orch,clna,1,NEG_AFFECTS_ORCHnafctCLNA
C0146951,C3830527,NEG_AFFECTS,Triton X-100,Detectable,orch,clna,1,NEG_AFFECTS_ORCHnafctCLNA
C0525005,C3830527,NEG_AFFECTS,Nelfinavir,Detectable,orch,clna,1,NEG_AFFECTS_ORCHnafctCLNA
C2983891,C3830527,NEG_AFFECTS,Apilimod,Detectable,orch,clna,1,NEG_AFFECTS_ORCHnafctCLNA
